6th Targeted Protein Degradation Summit
Spearheading Degrader Therapeutics Towards the First Approval
Last Fall, the world’s longest-standing and most comprehensive TPD meeting, the 6th Targeted Protein Degradation Summit, returned to Boston in 2023 as the trusted, definitive, end-to-end forum for the global network of protein degradation drug developers.
We ensured that entire teams stayed connected and were miles ahead of the curve with unmatched industry insights across early discovery, through the clinic and towards approval.
It spanned the full breadth of PROTAC and molecular glue clinical development, to unveiling next generation strategies including AbTACs, DUBTACs, bioPROTACs, ATACs, AUTOTACs and more, this meeting was the definitive opportunity to troubleshoot challenging problems and inspire new ideas with peers.
Relive the 2022 Event Highlights:
This was the Biggest Meeting in the Targeted Protein Degradation Calendar:
4 Specialized Tracks
6 Deep Dive Workshops
4 Days of Content
Uniting the World’s Leading Protein Degradation Minds:
Structural Genomics Consortium, University of Toronto
Vice President Protein Degradation Platform
Chief Executive Officer
Bristol Myers Squibb
Chief Scientific Officer
Head of Medicinal Chemistry & Drug Design